Beta detection
A detection approach focused on beta emissions from radiotracers, bringing molecular information to the surgical field.
MOLECULAR INSIGHT. SURGICAL DIRECTION.
Science that
guides surgery.
Bringing nuclear physics into the operating room. We develop beta detection technology to help surgeons explore radiotracer signals, right where decisions happen.
DEVELOPED FROM ITALIAN RESEARCHDesigned for the next step.
β BETA PROBE 1 Radioguided surgery technology
+
From a molecular signal.
To a surgical perspective.
Built on a foundation
of scientific research.
INFN spin-off
Patent licensed from INFN & Sapienza01 — THE TECHNOLOGY
A different signal.
A new perspective.
Radioguided surgery connects molecular targeting with intraoperative detection. Beta Probe 1 is Radiantis Research’s technology for exploring this connection through beta radiation.
RESEARCH, TRANSLATED INTO TECHNOLOGYIntraoperative insight
Probe measurements help researchers and clinicians investigate activity in tissue during a procedure.
A PET tracer research pathway
Published investigations include gallium-68 labelled tracers in neuroendocrine tumour and prostate cancer surgery.
THE PRINCIPLE
Follow the signal.
From molecular targeting to probe detection: a simplified overview of the radioguided research workflow.
Target
A selected radiotracer is administered according to the clinical study protocol.
Localise
The tracer’s biological targeting creates a pattern of activity that can be investigated.
Explore
The probe detects local radiation signals to support investigation within the surgical field.
Conceptual illustration. This overview is not a clinical protocol or instructions for use.
02 — THE SCIENCE
Progress starts
with evidence.
From detector research to clinical investigations. Explore selected peer-reviewed publications underlying the beta radioguided surgery approach.
01Investigating beta radioguidance
↗02A DROP-IN beta probe
↗
CLINICAL RESEARCH · NEUROENDOCRINE TUMOURS
Investigating beta radioguidance
with 68Ga-DOTATOC
Explore the published in-vivo investigation referenced in Radiantis’s scientific research.
FIRST-IN-HUMAN · ROBOTIC SURGERY
A DROP-IN beta probe
for PSMA-guided surgery
First-in-human validation and investigation of signal-to-background discrimination.
Explore the research foundations +
The publications describe specific research devices, populations and study conditions. Their findings should not be interpreted as universal performance claims for Beta Probe 1.
PHYSICS MEETS CLINICAL AMBITION
A shared purpose.
A more informed
surgical future.
Start a conversation ↗03 — OUR COMPANY
Italian research.
Connected expertise.
Radiantis Research is an innovative startup and spin-off of Italy’s National Institute for Nuclear Physics (INFN), licensing a patent from INFN and Sapienza University of Rome.
Our team
Engineering, physics and business working together.
Daniele Pili
CEO · Biomedical engineer
Francesco Collamati, PhD
CTO · Physicist
Lorenzo Caruso
Communications & Public Affairs
Alessandro Nardi
Strategy & Business Development Advisor
SCIENTIFIC BOARD
Clinical perspectives.
Scientific direction.
Francesco Ceci, MD, PhD
Medical consultant
Emilio Bertani, MD
Medical consultant
04 — CONNECT WITH RADIANTIS
The next step
starts with a conversation.
For clinical research, scientific collaboration and business enquiries, connect with our Corporate Affairs team.